ZEVASKYN is surgically applied to wounds at a ZEVASKYN Qualified Treatment Center

What to expect during the treatment journey

pretreatment Biopsy icon
Biopsy

Two 8 mm samples of your own skin (the size of 2 small peas) are collected using a method called a punch biopsy.

Dot Dot
~25 Days

After biopsy, you return home while the cells are sent to Abeona Therapeutics, where they are genetically modified and grown into credit card–sized ZEVASKYN sheets.

treatment Surgery icon
Surgery

For surgery, you travel to a ZEVASKYN Qualified Treatment Center, where ZEVASKYN sheets are applied in a single surgery under general or other appropriate anesthesia.

Dot Dot
5-10 Days

Treatment areas are undisturbed for 5-10 days to allow for healing.

posttreatment Discharge and follow-up icon
Discharge & Follow-up

You are discharged from the ZEVASKYN Qualified Treatment Center and follow-up is at your physician’s discretion.

Gus, smiling with his daughter, Noelle, who received ZEVASKYN treatment

Seeing these areas that were problematic, that hadn’t healed for years, are now staying, you know, wound-free for a while. And she’s like, wow, this is amazing. You know, so it’s a tough thing to go through. But the rewards are there.”

Learn about Noelle's journey through treatment Right-open Right-open
  • RDEB=recessive dystrophic epidermolysis bullosa.
Strong Together Network thumbnail
Square patient collage

Strong Together Network

Connect with a patient or caregiver who has experience with ZEVASKYN treatment

Connect with patients and caregivers Right-open Right-open

What is ZEVASKYN?

ZEVASKYN™ (prademagene zamikeracel) is a type of gene therapy made from your own skin cells that is surgically applied to treat wounds in both children and adults who have recessive dystrophic epidermolysis bullosa (RDEB).

Important Safety Information

  • Serious allergic reactions to ZEVASKYN can occur. Get medical help right away if you or your child experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen.
  • There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works.  Patients should be monitored for the rest of their lives to check for any signs of cancer.
  • ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated.
  • The most common side effects are pain from the procedure and itching.

This is not a complete list of side effects. Call your care team for medical advice about side effects. You may report side effects to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Post-Application Care

  • You may feel pain or itching at the treated area as it heals. Contact your doctor if you have: fever, increased drainage, worsening pain or swelling, or any other symptoms at or near the treated area.
  • Do not disturb the surgical dressing for 5—10 days, unless your doctor tells you otherwise.
  • Keep the dressing(s) dry. Do not soak the treated area(s) in water (like in a bath or pool) until the gauze backing falls off of the treated area(s), approximately 2—3 weeks after the surgery.

Product Manufacturing

  • ZEVASKYN is made from your own skin cells. In rare cases, the manufacturing process may not work. If this happens, your doctor may suggest taking another skin biopsy to repeat the manufacturing process.

Please see full Prescribing Information.

What is ZEVASKYN?

ZEVASKYN™ (prademagene zamikeracel) is a type of gene therapy made from your own skin cells that is surgically applied to treat wounds in both children and adults who have recessive dystrophic epidermolysis bullosa (RDEB).

Important Safety Information

  • Serious allergic reactions to ZEVASKYN can occur. Get medical help right away if you or your child experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen.
  • There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works.  Patients should be monitored for the rest of their lives to check for any signs of cancer.
  • ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated.
  • The most common side effects are pain from the procedure and itching.

This is not a complete list of side effects. Call your care team for medical advice about side effects. You may report side effects to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Post-Application Care

  • You may feel pain or itching at the treated area as it heals. Contact your doctor if you have: fever, increased drainage, worsening pain or swelling, or any other symptoms at or near the treated area.
  • Do not disturb the surgical dressing for 5—10 days, unless your doctor tells you otherwise.
  • Keep the dressing(s) dry. Do not soak the treated area(s) in water (like in a bath or pool) until the gauze backing falls off of the treated area(s), approximately 2—3 weeks after the surgery.

Product Manufacturing

  • ZEVASKYN is made from your own skin cells. In rare cases, the manufacturing process may not work. If this happens, your doctor may suggest taking another skin biopsy to repeat the manufacturing process.

Please see full Prescribing Information.

Abeona Therapeutics® logo

ZEVASKYN, Abeona Assist, and the related logos are registered trademarks of Abeona Therapeutics Inc. All other trademarks are the property of their respective owners.

© 2025 Abeona Therapeutics Inc. All rights reserved. US-COM-ZEV-250005  05/25